Streetbeat News

Stock Prices

SAR

Saratoga Investment (SAR) reported Q3 earnings of $0.90 per share, surpassing the Zacks Consensus Estimate of $0.82. This is a decrease from last year's $1.01 per share.

Portfolio Pulse from

January 08, 2025 | 11:30 pm

PENG

Penguin Solutions, Inc. (PENG) reported Q1 earnings of $0.49 per share, surpassing the Zacks Consensus Estimate of $0.40 per share. This marks a significant increase from $0.24 per share a year ago.

Portfolio Pulse from

January 08, 2025 | 11:30 pm

REGN

A class action lawsuit has been filed against Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) by Gainey McKenna & Egleston. The lawsuit is on behalf of investors who acquired Regeneron securities between November 2, 2023, and October 30, 2024, seeking damages under federal securities laws.

Portfolio Pulse from

January 08, 2025 | 11:30 pm

FC

Franklin Covey (FC) reported Q1 earnings of $0.09 per share, missing the Zacks Consensus Estimate of $0.22 per share. This is a significant drop from $0.36 per share a year ago.

Portfolio Pulse from

January 08, 2025 | 11:30 pm

TCEHY

Prosus N.V. is trading at a discount to its NAV, largely due to its holdings in Tencent, which has underperformed. This presents a potential 'double discount' opportunity for value investors. The Despegar.com acquisition is a small positive step for Prosus.

Portfolio Pulse from

January 08, 2025 | 11:30 pm

NVDA

Investing in certain AI stocks a year ago could have significantly increased your portfolio's value by the end of 2024. AI stocks have shown strong performance, offering substantial returns.

Portfolio Pulse from

January 08, 2025 | 11:30 pm

BIOA

A class action lawsuit has been filed against BioAge Labs Inc. (NASDAQ: BIOA) by Gainey McKenna & Egleston. The lawsuit is on behalf of investors who purchased BioAge securities during its IPO on September 26, 2024, and seeks damages under federal securities laws.

Portfolio Pulse from

January 08, 2025 | 11:30 pm

SENS

Senseonics Holdings, Inc. provided business updates, including preliminary 2024 results, a 365 launch update, and the cancellation of a special meeting. The company focuses on long-term, implantable continuous glucose monitoring systems.

Portfolio Pulse from

January 08, 2025 | 11:30 pm

BIOA

BioAge Labs, Inc. (NASDAQ:BIOA) is facing a lawsuit for alleged securities law violations. Investors who have suffered losses are encouraged to contact Levi & Korsinsky for potential recovery options.

Portfolio Pulse from

January 08, 2025 | 11:30 pm

TLN

Vanguard Group has increased its stake in Talen Energy Corp to 10.4%, reflecting growing interest in the company amid rising AI demand.

Portfolio Pulse from

January 08, 2025 | 11:15 pm